237 related articles for article (PubMed ID: 26242258)
1. PET and SPECT Radiotracers for Alzheimer's Disease.
Oukoloff K; Cieslikiewicz-Bouet M; Chao S; Da Costa Branquinho E; Bouteiller C; Jean L; Renard PY
Curr Med Chem; 2015; 22(28):3278-304. PubMed ID: 26242258
[TBL] [Abstract][Full Text] [Related]
2. SPECT and PET imaging in Alzheimer's disease.
Valotassiou V; Malamitsi J; Papatriantafyllou J; Dardiotis E; Tsougos I; Psimadas D; Alexiou S; Hadjigeorgiou G; Georgoulias P
Ann Nucl Med; 2018 Nov; 32(9):583-593. PubMed ID: 30128693
[TBL] [Abstract][Full Text] [Related]
3. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: novel PET/SPECT imaging probes for diagnosis of Alzheimer's disease.
Ono M; Saji H
J Pharmacol Sci; 2012; 118(3):338-44. PubMed ID: 22382657
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: spect and pet tracers for beta-amyloid imaging.
Valotassiou V; Archimandritis S; Sifakis N; Papatriantafyllou J; Georgoulias P
Curr Alzheimer Res; 2010 Sep; 7(6):477-86. PubMed ID: 20455860
[TBL] [Abstract][Full Text] [Related]
5. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
6. Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains.
Ono M
Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1029-39. PubMed ID: 19801854
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
[TBL] [Abstract][Full Text] [Related]
9. AD molecular: Imaging tau aggregates with positron emissions tomography.
Betthauser TJ
Prog Mol Biol Transl Sci; 2019; 165():107-138. PubMed ID: 31481160
[TBL] [Abstract][Full Text] [Related]
10. Novel PET/SPECT probes for imaging of tau in Alzheimer's disease.
Watanabe H; Ono M; Saji H
ScientificWorldJournal; 2015; 2015():124192. PubMed ID: 25879047
[TBL] [Abstract][Full Text] [Related]
11. [Molecular imaging by PET/SPECT].
Ono M
Yakugaku Zasshi; 2009 Mar; 129(3):279-87. PubMed ID: 19252385
[TBL] [Abstract][Full Text] [Related]
12. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
13. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
14. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
15. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.
Villemagne VL; Rowe CC; Macfarlane S; Novakovic KE; Masters CL
J Clin Neurosci; 2005 Apr; 12(3):221-30. PubMed ID: 15851069
[TBL] [Abstract][Full Text] [Related]
16. PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape.
Uzuegbunam BC; Librizzi D; Hooshyar Yousefi B
Molecules; 2020 Feb; 25(4):. PubMed ID: 32098280
[TBL] [Abstract][Full Text] [Related]
17. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
[TBL] [Abstract][Full Text] [Related]
18. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
19. A dual fluorinated and iodinated radiotracer for PET and SPECT imaging of β-amyloid plaques in the brain.
Watanabe H; Ono M; Kimura H; Kagawa S; Nishii R; Fuchigami T; Haratake M; Nakayama M; Saji H
Bioorg Med Chem Lett; 2011 Nov; 21(21):6519-22. PubMed ID: 21920750
[TBL] [Abstract][Full Text] [Related]
20. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques.
Yang Y; Zhang X; Cui M; Zhang J; Guo Z; Li Y; Zhang X; Dai J; Liu B
Sci Rep; 2015 Jul; 5():12084. PubMed ID: 26170205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
